Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.

Leishmaniasis is a neglected disease that affects 12 million people living mainly in developing countries. Herein, 24 new N-oxide-containing compounds were synthesized followed by in vitro and in vivo evaluation of their antileishmanial activity. Compound 4f, a furoxan derivative, was particularly r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leandro da Costa Clementino, Guilherme Felipe Santos Fernandes, Igor Muccilo Prokopczyk, Wilquer Castro Laurindo, Danyelle Toyama, Bruno Pereira Motta, Amanda Martins Baviera, Flávio Henrique-Silva, Jean Leandro Dos Santos, Marcia A S Graminha
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/518d903179ec47c3a56720c797f90773
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:518d903179ec47c3a56720c797f90773
record_format dspace
spelling oai:doaj.org-article:518d903179ec47c3a56720c797f907732021-12-02T20:04:36ZDesign, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.1932-620310.1371/journal.pone.0259008https://doaj.org/article/518d903179ec47c3a56720c797f907732021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0259008https://doaj.org/toc/1932-6203Leishmaniasis is a neglected disease that affects 12 million people living mainly in developing countries. Herein, 24 new N-oxide-containing compounds were synthesized followed by in vitro and in vivo evaluation of their antileishmanial activity. Compound 4f, a furoxan derivative, was particularly remarkable in this regard, with EC50 value of 3.6 μM against L. infantum amastigote forms and CC50 value superior to 500 μM against murine peritoneal macrophages. In vitro studies suggested that 4f may act by a dual effect, by releasing nitric oxide after biotransformation and by inhibiting cysteine protease CPB (IC50: 4.5 μM). In vivo studies using an acute model of infection showed that compound 4f at 7.7 mg/Kg reduced ~90% of parasite burden in the liver and spleen of L. infantum-infected BALB/c mice. Altogether, these outcomes highlight furoxan 4f as a promising compound for further evaluation as an antileishmanial agent.Leandro da Costa ClementinoGuilherme Felipe Santos FernandesIgor Muccilo ProkopczykWilquer Castro LaurindoDanyelle ToyamaBruno Pereira MottaAmanda Martins BavieraFlávio Henrique-SilvaJean Leandro Dos SantosMarcia A S GraminhaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0259008 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Leandro da Costa Clementino
Guilherme Felipe Santos Fernandes
Igor Muccilo Prokopczyk
Wilquer Castro Laurindo
Danyelle Toyama
Bruno Pereira Motta
Amanda Martins Baviera
Flávio Henrique-Silva
Jean Leandro Dos Santos
Marcia A S Graminha
Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.
description Leishmaniasis is a neglected disease that affects 12 million people living mainly in developing countries. Herein, 24 new N-oxide-containing compounds were synthesized followed by in vitro and in vivo evaluation of their antileishmanial activity. Compound 4f, a furoxan derivative, was particularly remarkable in this regard, with EC50 value of 3.6 μM against L. infantum amastigote forms and CC50 value superior to 500 μM against murine peritoneal macrophages. In vitro studies suggested that 4f may act by a dual effect, by releasing nitric oxide after biotransformation and by inhibiting cysteine protease CPB (IC50: 4.5 μM). In vivo studies using an acute model of infection showed that compound 4f at 7.7 mg/Kg reduced ~90% of parasite burden in the liver and spleen of L. infantum-infected BALB/c mice. Altogether, these outcomes highlight furoxan 4f as a promising compound for further evaluation as an antileishmanial agent.
format article
author Leandro da Costa Clementino
Guilherme Felipe Santos Fernandes
Igor Muccilo Prokopczyk
Wilquer Castro Laurindo
Danyelle Toyama
Bruno Pereira Motta
Amanda Martins Baviera
Flávio Henrique-Silva
Jean Leandro Dos Santos
Marcia A S Graminha
author_facet Leandro da Costa Clementino
Guilherme Felipe Santos Fernandes
Igor Muccilo Prokopczyk
Wilquer Castro Laurindo
Danyelle Toyama
Bruno Pereira Motta
Amanda Martins Baviera
Flávio Henrique-Silva
Jean Leandro Dos Santos
Marcia A S Graminha
author_sort Leandro da Costa Clementino
title Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.
title_short Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.
title_full Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.
title_fullStr Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.
title_full_unstemmed Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.
title_sort design, synthesis and biological evaluation of n-oxide derivatives with potent in vivo antileishmanial activity.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/518d903179ec47c3a56720c797f90773
work_keys_str_mv AT leandrodacostaclementino designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT guilhermefelipesantosfernandes designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT igormucciloprokopczyk designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT wilquercastrolaurindo designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT danyelletoyama designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT brunopereiramotta designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT amandamartinsbaviera designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT flaviohenriquesilva designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT jeanleandrodossantos designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
AT marciaasgraminha designsynthesisandbiologicalevaluationofnoxidederivativeswithpotentinvivoantileishmanialactivity
_version_ 1718375540152336384